Munetake Shimabe

1.1k total citations
20 papers, 862 citations indexed

About

Munetake Shimabe is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Munetake Shimabe has authored 20 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Munetake Shimabe's work include Acute Myeloid Leukemia Research (8 papers), Epigenetics and DNA Methylation (4 papers) and Reproductive System and Pregnancy (4 papers). Munetake Shimabe is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Epigenetics and DNA Methylation (4 papers) and Reproductive System and Pregnancy (4 papers). Munetake Shimabe collaborates with scholars based in Japan and United States. Munetake Shimabe's co-authors include Mineo Kurokawa, Susumu Goyama, Motoshi Ichikawa, Tomohiko Sato, Yoichi Imai, Akihide Yoshimi, Masahiro Nakagawa, Shunya Arai, Go Yamamoto and Shigeru Chiba and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Nature Biotechnology.

In The Last Decade

Munetake Shimabe

20 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Munetake Shimabe Japan 11 498 429 182 86 83 20 862
Mikkel Bruhn Schuster Denmark 15 641 1.3× 379 0.9× 180 1.0× 56 0.7× 116 1.4× 24 895
Kim L. Rice United States 12 550 1.1× 254 0.6× 98 0.5× 56 0.7× 112 1.3× 17 777
Luisella Luchetti Italy 10 420 0.8× 361 0.8× 197 1.1× 73 0.8× 110 1.3× 14 793
Wendy A. Hudson United States 11 520 1.0× 407 0.9× 87 0.5× 44 0.5× 95 1.1× 15 720
Sonja Babovic Canada 9 415 0.8× 308 0.7× 296 1.6× 41 0.5× 101 1.2× 11 813
Nathalie Beslu Canada 10 575 1.2× 406 0.9× 177 1.0× 73 0.8× 113 1.4× 12 897
Jason E. Farrar United States 15 661 1.3× 204 0.5× 132 0.7× 144 1.7× 131 1.6× 61 914
Jessica McLeod Canada 7 533 1.1× 534 1.2× 339 1.9× 51 0.6× 150 1.8× 21 977
Yixiao Gong United States 10 574 1.2× 285 0.7× 162 0.9× 53 0.6× 189 2.3× 14 915
Yasuhiko Kamikubo Japan 16 656 1.3× 448 1.0× 146 0.8× 53 0.6× 156 1.9× 43 1.0k

Countries citing papers authored by Munetake Shimabe

Since Specialization
Citations

This map shows the geographic impact of Munetake Shimabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Munetake Shimabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Munetake Shimabe more than expected).

Fields of papers citing papers by Munetake Shimabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Munetake Shimabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Munetake Shimabe. The network helps show where Munetake Shimabe may publish in the future.

Co-authorship network of co-authors of Munetake Shimabe

This figure shows the co-authorship network connecting the top 25 collaborators of Munetake Shimabe. A scholar is included among the top collaborators of Munetake Shimabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Munetake Shimabe. Munetake Shimabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Furihata, Kenichi, Yoh Ishiguro, Naoki Yoshimura, et al.. (2021). A Phase 1 Study of KHK4083: A Single‐Blind, Randomized, Placebo‐Controlled Single‐Ascending‐Dose Study in Healthy Adults and an Open‐Label Multiple‐Dose Study in Patients With Ulcerative Colitis. Clinical Pharmacology in Drug Development. 10(8). 870–883. 5 indexed citations
2.
3.
Shimabe, Munetake, et al.. (2015). The novel CA IX inhibition antibody chKM4927 shows anti-tumor efficacy in vivo.. PubMed. 35(4). 1997–2004. 2 indexed citations
4.
Akiyama, Tadakazu, Shin‐ichiro Takayanagi, Kohta Miyawaki, et al.. (2015). First Preclinical Report of the Efficacy and PD Results of KHK2823, a Non-Fucosylated Fully Human Monoclonal Antibody Against IL-3Rα. Blood. 126(23). 1349–1349. 10 indexed citations
5.
Kataoka, Keisuke, Tomohiko Sato, Akihide Yoshimi, et al.. (2011). Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity. The Journal of Experimental Medicine. 208(12). 2403–2416. 126 indexed citations
6.
Yoshimi, Akihide, Susumu Goyama, Naoko Watanabe‐Okochi, et al.. (2011). Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. Blood. 117(13). 3617–3628. 117 indexed citations
7.
Nakagawa, Masahiro, Munetake Shimabe, Naoko Watanabe‐Okochi, et al.. (2011). AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors. Blood. 118(25). 6626–6637. 47 indexed citations
8.
Arai, Shunya, Akihide Yoshimi, Munetake Shimabe, et al.. (2010). Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells. Blood. 117(23). 6304–6314. 68 indexed citations
9.
Shimabe, Munetake, Susumu Goyama, Naoko Watanabe‐Okochi, et al.. (2009). Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells. Oncogene. 28(49). 4364–4374. 52 indexed citations
10.
Goyama, Susumu, Eriko Nitta, Toshihiko Yoshino, et al.. (2009). EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization. Leukemia. 24(1). 81–88. 60 indexed citations
11.
Nakagawa, Masahiro, Munetake Shimabe, Nahoko Nishimoto, et al.. (2009). AML1/Runx1 Is a Cytoplasmic Attenuator of NF-Kb Signaling: Implication in Pathogenesis and Targeted Therapy of AML1-Related Leukemia.. Blood. 114(22). 1962–1962. 2 indexed citations
12.
Goyama, Susumu, Go Yamamoto, Munetake Shimabe, et al.. (2008). Evi-1 Is a Critical Regulator for Hematopoietic Stem Cells and Transformed Leukemic Cells. Cell stem cell. 3(2). 207–220. 221 indexed citations
13.
Arai, Shunya, Susumu Goyama, Munetake Shimabe, et al.. (2008). Evi-1 Is a Direct Target of MLL Oncoproteins in Hematopoietic Stem Cells. Blood. 112(11). 3807–3807. 1 indexed citations
14.
Shimabe, Munetake, Susumu Goyama, Motoshi Ichikawa, et al.. (2008). Pbx-1 Is a Direct Target of Evi-1 in Hematopoietic Stem/Progenitors and Leukemic Cells.. Blood. 112(11). 1192–1192. 2 indexed citations
15.
Kai, Masayuki, Kazuhiro Motoki, Hideaki Yoshida, et al.. (2007). Switching constant domains enhances agonist activities of antibodies to a thrombopoietin receptor. Nature Biotechnology. 26(2). 209–211. 23 indexed citations
16.
Kai, Masayuki, Kazuhiro Motoki, Hideaki Yoshida, et al.. (2006). Domain Subclass Conversion Improved Activity of Anti-Mpl Agonist Antibodies in the Form of Whole IgG.. Blood. 108(11). 1134–1134. 10 indexed citations
17.
Komatsu, Kouji, Noboru MANABE, Minako Kiso, Munetake Shimabe, & Hajime MIYAMOTO. (2003). Changes in localization of immune cells and cytokines in corpora lutea during luteolysis in murine ovaries. Journal of Experimental Zoology Part A Comparative Experimental Biology. 296A(2). 152–159. 35 indexed citations
18.
Komatsu, Kouji, Noboru MANABE, Minako Kiso, Munetake Shimabe, & Hajime MIYAMOTO. (2003). Soluble Fas (FasB) regulates luteal cell apoptosis during luteolysis in murine ovaries. Molecular Reproduction and Development. 65(4). 345–352. 26 indexed citations
19.
Kiso, Minako, Noboru MANABE, Kouji Komatsu, Munetake Shimabe, & Hajime MIYAMOTO. (2003). Abnormal Structural Luteolysis in Ovaries of the Senescence Accelerated Mouse (SAM): Expression of Fas Ligand/Fas-Mediated Apoptosis Signaling Molecules in Luteal Cells. Journal of Reproduction and Development. 49(6). 457–463. 4 indexed citations
20.
MANABE, Noboru, et al.. (2003). Abnormal accumulation of corpora lutea in ovaries of the senescence accelerated mouse prone (SAMP1). International Congress Series. 1260. 179–185. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikkel Bruhn Schuster Breakdown of academic impact, for papers by Kim L. Rice Breakdown of academic impact, for papers by Luisella Luchetti Breakdown of academic impact, for papers by Wendy A. Hudson Breakdown of academic impact, for papers by Sonja Babovic Breakdown of academic impact, for papers by Nathalie Beslu Breakdown of academic impact, for papers by Jason E. Farrar Breakdown of academic impact, for papers by Jessica McLeod Breakdown of academic impact, for papers by Yixiao Gong Breakdown of academic impact, for papers by Yasuhiko Kamikubo
Rankless by CCL
2026